{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:25:12Z","timestamp":1792131912255,"version":"4.4.0"},"reference-count":198,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Polish National Science Center","award":["UMO-2015\/17\/N\/NZ7\/01094"],"award-info":[{"award-number":["UMO-2015\/17\/N\/NZ7\/01094"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Tauroursodeoxycholic acid (TUDCA) is a naturally occurring hydrophilic bile acid that has been used for centuries in Chinese medicine. Chemically, TUDCA is a taurine conjugate of ursodeoxycholic acid (UDCA), which in contemporary pharmacology is approved by Food and Drug Administration (FDA) for treatment of primary biliary cholangitis. Interestingly, numerous recent studies demonstrate that mechanisms of TUDCA functioning extend beyond hepatobiliary disorders. Thus, TUDCA has been demonstrated to display potential therapeutic benefits in various models of many diseases such as diabetes, obesity, and neurodegenerative diseases, mostly due to its cytoprotective effect. The mechanisms underlying this cytoprotective activity have been mainly attributed to alleviation of endoplasmic reticulum (ER) stress and stabilization of the unfolded protein response (UPR), which contributed to naming TUDCA as a chemical chaperone. Apart from that, TUDCA has also been found to reduce oxidative stress, suppress apoptosis, and decrease inflammation in many in-vitro and in-vivo models of various diseases. The latest research suggests that TUDCA can also play a role as an epigenetic modulator and act as therapeutic agent in certain types of cancer. Nevertheless, despite the massive amount of evidence demonstrating positive effects of TUDCA in pre-clinical studies, there are certain limitations restraining its wide use in patients. Here, molecular and cellular modes of action of TUDCA are described and therapeutic opportunities and limitations of this bile acid are discussed.<\/jats:p>","DOI":"10.3390\/cells8121471","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T11:06:03Z","timestamp":1574247963000},"page":"1471","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":230,"title":["Tauroursodeoxycholate\u2014Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives"],"prefix":"10.3390","volume":"8","author":[{"given":"Magdalena","family":"Kusaczuk","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Biochemistry, Medical University of Bia\u0142ystok, Mickiewicza 2A, 15-222 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.3748\/wjg.v20.i29.9952","article-title":"Therapeutic uses of animal biles in traditional Chinese medicine: An ethnopharmacological, biophysical chemical and medicinal review","volume":"20","author":"Wang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1574-6968.2004.tb09568.x","article-title":"Epimerization of chenodeoxycholic acid to ursodeoxycholic acid by Clostridium baratii isolated from human feces","volume":"235","author":"Lepercq","year":"2004","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fnagi.2016.00263","article-title":"Bile acids in neurodegenerative disorders","volume":"8","author":"Ackerman","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7453\/gahmj.2014.017","article-title":"The Unexpected uses of urso- and tauroursodeoxycholic acid in the treatment of non-liver diseases","volume":"3","author":"Vang","year":"2014","journal-title":"Global Adv. Health Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1096\/fj.201600275R","article-title":"Effects of bile acids on neurological function and disease","volume":"30","author":"McMillin","year":"2016","journal-title":"FASEB J."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kiriyama, Y., and Nochi, H. (2019). The biosynthesis, signaling, and neurological functions of bile acids. Biomolecules, 9.","DOI":"10.3390\/biom9060232"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/hep.26228","article-title":"\u03b21 integrin is a long-sought sensor for tauroursodeoxycholic acid","volume":"57","author":"Beuers","year":"2013","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/hep.25992","article-title":"\u03b15\u03b21-integrins are sensors for tauroursodeoxycholic acid in hepatocytes","volume":"57","author":"Gohlke","year":"2013","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.24681","article-title":"Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes","volume":"55","author":"Studer","year":"2012","journal-title":"Hepatology"},{"key":"ref_11","first-page":"15","article-title":"The western diet and lifestyle and diseases of civilization","volume":"2","author":"Lindeberg","year":"2011","journal-title":"Res. Rep. Clin. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2174\/1381612821666150105160059","article-title":"Phenylbutyric acid: Simple structure- multiple effects","volume":"21","author":"Kusaczuk","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/jbiol186","article-title":"Q&A: What are pharmacological chaperones and why are they interesting?","volume":"8","author":"Ringe","year":"2009","journal-title":"J. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4161\/pri.28938","article-title":"The therapeutic potential of chemical chaperones in protein folding diseases","volume":"8","author":"Cortez","year":"2014","journal-title":"Prion"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nsmb.1591","article-title":"Converging concepts of protein folding in vitro and in vivo","volume":"16","author":"Hartl","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2174\/138955708785132783","article-title":"Protein misfolding in conformational disorders: Rescue of folding defects and chemical chaperoning","volume":"8","author":"Leandro","year":"2008","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.bbapap.2006.08.012","article-title":"Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs","volume":"1764","author":"Arakawa","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/356487","article-title":"Amelioration of glucolipotoxicity-induced endoplasmic reticulum stress by a \u201cchemical chaperone\u201d in human THP-1 monocytes","volume":"28","author":"Lenin","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bbrc.2010.06.022","article-title":"Tauroursodeoxycholate (TUDCA), chemical chaperone, enhances function of islets by reducing ER stress","volume":"397","author":"Lee","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.febslet.2010.12.044","article-title":"The chemical chaperones tauroursodeoxycholic and 4-phenylbutyric acid accelerate thyroid hormone activation and energy expenditure","volume":"585","author":"Ribich","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Paridaens, A., Raevens, S., Devisscher, L., Bogaerts, E., Verhelst, X., Hoorens, A., Van Vlierberghe, H., van Grunsven, L.A., Geerts, A., and Colle, I. (2017). Modulation of the unfolded protein response by tauroursodeoxycholic acid counteracts apoptotic cell death and fibrosis in a mouse model for secondary biliary liver fibrosis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18010214"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Wang, X., Zheng, G., Shan, Q., Lu, J., Fan, S., Sun, C., Wu, D., Zhang, C., and Su, W. (2016). Troxerutin attenuates enhancement of hepatic gluconeogenesis by inhibiting NOD activation-mediated inflammation in high-fat diet-treated mice. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18010031"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s42269-019-0089-7","article-title":"Potential prophylactic effect of chemical chaperones for alleviation of endoplasmic reticulum stress in experimental diabetic cataract","volume":"43","author":"Elhossary","year":"2019","journal-title":"Bull. Natl. Res. Cent."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1046\/j.1471-4159.2000.0752368.x","article-title":"Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: Evidence for a mitochondrial pathway independent of the permeability transition","volume":"75","author":"Rodrigues","year":"2000","journal-title":"J. Neurochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03401914","article-title":"Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production","volume":"4","author":"Rodrigues","year":"1998","journal-title":"Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/jhep.2002.34511","article-title":"Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes","volume":"36","author":"Azzaroli","year":"2002","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12035-012-8295-4","article-title":"Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson\u2019s disease","volume":"46","author":"Carvalho","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI1325","article-title":"A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation","volume":"101","author":"Rodrigues","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.20246","article-title":"Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways","volume":"39","author":"Schoemaker","year":"2004","journal-title":"Hepatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.cdd.4400560","article-title":"Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation","volume":"6","author":"Rodrigues","year":"1999","journal-title":"Cell Death Differ."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jhep.2005.01.026","article-title":"A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid","volume":"42","author":"Castro","year":"2005","journal-title":"J. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"G327","DOI":"10.1152\/ajpgi.00093.2007","article-title":"Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes","volume":"293","author":"Castro","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"48831","DOI":"10.1074\/jbc.M300468200","article-title":"Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor b1-induced apoptosis of rat hepatocytes","volume":"278","author":"Ma","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"34250","DOI":"10.1074\/jbc.M704075200","article-title":"p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis","volume":"282","author":"Amaral","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1471-4159.2004.02517.x","article-title":"Inhibition of the E2F-1\/p53\/Bax pathway by tauroursodeoxycholic acid in amyloid beta-peptide-induced apoptosis of PC12 cells","volume":"90","author":"Ramalho","year":"2004","journal-title":"J. Neurochem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.20870","article-title":"Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-\u03b21-induced apoptosis in rat hepatocytes","volume":"42","author":"Amaral","year":"2005","journal-title":"Hepatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1210\/me.2006-0063","article-title":"Functional modulation of nuclear steroid receptors by tauroursodeoxycholic acid reduces amyloid beta-peptide-induced apoptosis","volume":"20","author":"Amaral","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1124\/jpet.104.070532","article-title":"The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of Bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons","volume":"311","author":"Castro","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"27876","DOI":"10.1074\/jbc.M112.377549","article-title":"Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress","volume":"287","author":"Cash","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_40","first-page":"G387","article-title":"Mechanisms of hepatic toxicity. I. TNF-induced liver injury","volume":"275","author":"Bradham","year":"1998","journal-title":"Am. J. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2119\/2003-00042.Rodrigues","article-title":"Tauroursodeoxycholic acid prevents amyloid \u03b2-peptide-induced neuronal death through a phosphatidylinositol 3-kinase-dependent signaling pathway","volume":"9","author":"Castro","year":"2003","journal-title":"Mol Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fncel.2017.00193","article-title":"Administration of tauroursodeoxycholic acid attenuates early brain injury via Akt pathway activation","volume":"11","author":"Sun","year":"2017","journal-title":"Front. Cell Neurosci."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Li, S., Tan, H.Y., Wang, N., Hong, M., Li, L., Cheung, F., and Feng, Y. (2016). Substitutes for bear bile for the treatment of liver diseases: Research progress and future perspective. Evid. Based Complementary Altern. Med., 430507.","DOI":"10.1155\/2016\/4305074"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/157488407780598171","article-title":"Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases","volume":"2","author":"Festi","year":"2007","journal-title":"Curr. Clin. Pharmacol."},{"key":"ref_45","first-page":"S3","article-title":"Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: An overview of their mechanisms of action","volume":"36","author":"Poupon","year":"2012","journal-title":"Clin. Res. Hepatol. Gas."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1746-4269-5-2","article-title":"Bear bile: Dilemma of traditional medicinal use and animal protection","volume":"5","author":"Feng","year":"2009","journal-title":"J. Ethnobiol. Ethnomed."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1385\/CRIAI:28:2:135","article-title":"Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis","volume":"28","author":"Rust","year":"2005","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/gut.32.9.1061","article-title":"Ursodeoxycholic acid in chronic liver disease","volume":"32","author":"Caestecker","year":"1991","journal-title":"Gut"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jhep.2007.12.023","article-title":"High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective","volume":"48","author":"Cullen","year":"2008","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.3748\/wjg.v12.i22.3487","article-title":"Ursodeoxycholic acid treatment of vanishing bile duct syndromes","volume":"12","author":"Pusl","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Baiocchi, L., Zhou, T., Liangpunsakul, S., Lenci, I., Santopaolo, F., and Meng, F. (2019). Dual role of bile acids on the biliary epithelium: Friend or foe?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081869"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jhep.2010.08.030","article-title":"A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis","volume":"54","author":"Ratziu","year":"2011","journal-title":"Hepatology"},{"key":"ref_54","first-page":"1247","article-title":"Ursodeoxycholic acid for nonalcoholic steatohepatitis","volume":"24","author":"Wu","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000322298","article-title":"Steroid and ursodesoxycholic acid combination therapy in severe drug-induced liver injury","volume":"84","author":"Were","year":"2011","journal-title":"Digestion"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/liv.13477","article-title":"Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review","volume":"37","author":"Suraweera","year":"2017","journal-title":"Liver Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/gut.38.3.439","article-title":"Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis","volume":"38","author":"Setchell","year":"1996","journal-title":"Gut"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3389\/fphar.2018.01283","article-title":"Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles","volume":"9","author":"Stanimirov","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbamem.2008.12.008","article-title":"The role of membrane cholesterol in determining bile acid cytotoxicity and cytoprotection of ursodeoxycholic acid","volume":"1788","author":"Zhou","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11596-013-1095-x","article-title":"Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: A double-blind randomized controlled trial","volume":"33","author":"Pan","year":"2013","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1097\/MD.0000000000005391","article-title":"A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis","volume":"95","author":"Ma","year":"2016","journal-title":"Medicine"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1053\/jhep.2001.28510","article-title":"Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione","volume":"34","author":"Colell","year":"2001","journal-title":"Hepatology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"17562848","DOI":"10.1177\/1756284818787400","article-title":"Cholestatic liver diseases: New targets, new therapies","volume":"11","author":"Santiago","year":"2018","journal-title":"Therap. Adv. Gastroenterol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis","volume":"3","author":"Beuers","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1172\/JCI116921","article-title":"Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis","volume":"92","author":"Beuers","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_67","first-page":"G243","article-title":"Ursodeoxycholate mobilizes intracellular Ca++ and activates phosphorylase a in isolated hepatocytes","volume":"264","author":"Bouscarel","year":"1993","journal-title":"Am. J. Physiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/0006-291X(90)90800-3","article-title":"Tauroursodeoxycholic acid inhibits the cytosolic Ca++ increase in human neutrophils stimulated by formyl-methionyl-leucyl-phenylalanine","volume":"171","author":"Beuers","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0016-5085(93)90433-D","article-title":"Effects of tauroursodeoxycholic acid on cytosolic Ca++ signals in isolated rat hepatocytes","volume":"104","author":"Beuers","year":"1993","journal-title":"Gastroenterology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1053\/gast.1996.v110.pm8613063","article-title":"Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes","volume":"110","author":"Beuers","year":"1996","journal-title":"Gastroenterology"},{"key":"ref_71","first-page":"G300","article-title":"Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: A role for PKC","volume":"268","author":"Bouscarel","year":"1995","journal-title":"Am. J. Physiol."},{"key":"ref_72","first-page":"G293","article-title":"Hepatocellular protein kinase C activation by bile acids: Implications for regulation of cholesterol 7 alpha-hydroxylase","volume":"271","author":"Stravitz","year":"1996","journal-title":"Am. J. Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/gast.2001.26262","article-title":"Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats","volume":"121","author":"Kurz","year":"2001","journal-title":"Gastroenterology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1053\/gast.1997.v113.pm9322526","article-title":"Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver","volume":"113","author":"Schliess","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2353\/ajpath.2006.050126","article-title":"Ca2+ -dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts","volume":"168","author":"Marzioni","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0016-5085(03)00274-9","article-title":"Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis","volume":"124","author":"Kurz","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hep.29804","article-title":"Bile acids stimulate cholangiocyte fluid secretion by activation of transmembrane member 16A Cl- channels","volume":"68","author":"Li","year":"2018","journal-title":"Hepatology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2001.24034","article-title":"Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver","volume":"33","author":"Beuers","year":"2001","journal-title":"Hepatology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.51.1.113","article-title":"Hepatoprotection with tauroursodeoxycholate and beta muricholate against taurolithocholate induced cholestasis: Involvement of signal transduction pathways","volume":"51","author":"Milkiewicz","year":"2002","journal-title":"Gut"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/gut.2007.140871","article-title":"Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-\/PKA-dependent mechanism in rat liver","volume":"57","author":"Wimmer","year":"2008","journal-title":"Gut"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/labinvest.3700371","article-title":"Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver","volume":"86","author":"Dombrowski","year":"2006","journal-title":"Lab. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2362.2002.01002.x","article-title":"Tauroursodeoxycholic acid mobilizes alpha-PKC after uptake in human HepG2 hepatoma cells","volume":"32","author":"Glasova","year":"2002","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Chipurupalli, S., Kannan, E., Tergaonkar, V., D\u2019Andrea, R., and Robinson, N. (2019). Hypoxia Induced ER Stress Response as an Adaptive Mechanism in Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030749"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.2174\/1381612811319150016","article-title":"Molecular chaperone ORP150 in ER stress-related diseases","volume":"19","author":"Kusaczuk","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1038\/s41598-017-03940-1","article-title":"Chemical chaperone, TUDCA unlike PBA, mitigates protein aggregation efficiently and resists ER and non-ER stress induced HepG2 cell death","volume":"7","author":"Uppala","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.abb.2014.12.031","article-title":"Tauroursodeoxycholic acid prevents stress induced aggregation of proteins in vitro and promotes PERK activation in HepG2 cells","volume":"568","author":"Gani","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/3-540-29717-0_16","article-title":"Chemical chaperones: Mechanisms of action and potential use","volume":"172","author":"Papp","year":"2006","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1203\/00006450-200212000-00004","article-title":"Chemical chaperones: A pharmacological strategy for disorders of protein folding and trafficking","volume":"52","author":"Perlmutter","year":"2002","journal-title":"Pediatr. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1021\/cb500798y","article-title":"Classification of chemical chaperones based on their effect on protein folding landscapes","volume":"10","author":"Dandage","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"15866","DOI":"10.1074\/jbc.M110.107722","article-title":"Rescue of cystathionine beta-synthase (CBS) mutants with chemical chaperones: Purification and characterization of eight CBS mutant enzymes","volume":"285","author":"Majtan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02265","article-title":"Therapeutic approaches to protein-misfolding diseases","volume":"426","author":"Cohen","year":"2003","journal-title":"Nature"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fnins.2017.00185","article-title":"Protein quality control by molecular chaperones in neurodegeneration","volume":"11","author":"Ciechanover","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bbrc.2013.01.131","article-title":"Sodium tauroursodeoxycholate prevents paraquat-induced cell death by suppressing endoplasmic reticulum stress responses in human lung epithelial A549 cells","volume":"432","author":"Omura","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Lee, J.H., Yoon, Y.M., and Lee, S.H. (2019). TUDCA-treated mesenchymal stem cells protect against ER Stress in the hippocampus of a murine chronic kidney disease model. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030613"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10557-018-6844-4","article-title":"The role of tauroursodeoxycholic acid on dedifferentiation of vascular smooth muscle cells by modulation of endoplasmic reticulum stress and as an oral drug inhibiting in-stent restenosis","volume":"33","author":"Luo","year":"2019","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000056179","article-title":"Activation of the metallothionein IIA promoter and other key stress response elements by ursodeoxycholate in HepG2 cells: Relevance to the cytoprotective function of ursodeoxycholate","volume":"65","author":"Bernstein","year":"2002","journal-title":"Pharmacology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1006\/bbrc.1999.1403","article-title":"Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants","volume":"263","author":"Mitsuyoshi","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/HYPERTENSIONAHA.112.192500","article-title":"A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus","volume":"60","author":"Kassan","year":"2012","journal-title":"Hypertension"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2337\/db10-0308","article-title":"Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women","volume":"59","author":"Kars","year":"2010","journal-title":"Diabetes"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuroscience.2013.08.053","article-title":"Tauroursodeoxycholic acid protects retinal neural cells from cell death induced by prolonged exposure to elevated glucose","volume":"253","author":"Gaspar","year":"2013","journal-title":"Neuroscience"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1681\/ASN.2016101123","article-title":"Farnesoid X receptor agonism protects against diabetic tubulopathy: Potential add-on therapy for diabetic nephropathy","volume":"28","author":"Marquardt","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Fang, L., Zhou, Y., Cao, H., Wen, P., Jiang, L., He, W., Dai, C., and Yang, J. (2013). Autophagy attenuates diabetic glomerular damage through protection of hyperglycemia-induced podocyte injury. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060546"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fphys.2019.00561","article-title":"The bile acid TUDCA improves beta-cell mass and reduces insulin degradation in mice with early-stage of type-1 diabetes","volume":"10","author":"Bronczek","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Turdi, S., Hu, N., and Ren, J. (2013). Tauroursodeoxycholic acid mitigates high fat diet-induced cardiomyocyte contractile and intracellular Ca2+ anomalies [published correction appears in PLoS One. 2016;11(4):e0154907]. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063615"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.2337\/db08-0604","article-title":"Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals","volume":"57","author":"Boden","year":"2008","journal-title":"Diabetes"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1210\/jc.2008-1001","article-title":"Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects","volume":"93","author":"Sharma","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"14876","DOI":"10.1038\/s41598-017-13974-0","article-title":"Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice","volume":"7","author":"Vettorazzi","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_108","first-page":"43","article-title":"Tauroursodeoxycholate, a chemical chaperone, prevents palmitate-induced apoptosis in pancreatic \u03b2-cells by reducing ER stress","volume":"121","author":"Zhu","year":"2013","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"G773","DOI":"10.1152\/ajpgi.00483.2010","article-title":"Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, acinar cell damage, and systemic inflammation in acute pancreatitis","volume":"301","author":"Seyhun","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Live Physiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00125-012-2782-z","article-title":"Endoplasmic reticulum stress upregulates protein tyrosine phosphatase 1B and impairs glucose uptake in cultured myotubes","volume":"56","author":"Panzhinskiy","year":"2013","journal-title":"Diabetologia"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000479967","article-title":"Tauroursodeoxycholic acid reduces arterial stiffness and improves endothelial dysfunction in type 2 diabetic mice","volume":"54","author":"Battson","year":"2017","journal-title":"J. Vasc. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"ra156","DOI":"10.1126\/scitranslmed.3006534","article-title":"Restoration of the unfolded protein response in pancreatic \u03b2 cells protects mice against type 1 diabetes","volume":"5","author":"Engin","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.metabol.2015.10.021","article-title":"The bile acid TUDCA increases glucose-induced insulin secretion via the cAMP\/PKA pathway in pancreatic beta cells","volume":"65","author":"Vettorazzi","year":"2016","journal-title":"Metabolism"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/db11-0815","article-title":"Bile acids acutely stimulate insulin secretion of mouse \u03b2-cells via farnesoid X receptor activation and K(ATP) channel inhibition","volume":"61","author":"Wagner","year":"2012","journal-title":"Diabetes"},{"key":"ref_115","first-page":"1753","article-title":"Tauroursodeoxycholic acid inhibits TNF-induced lipolysis in 3T3-L1 adipocytes via the IRE-JNK-perilipin-A signaling pathway","volume":"15","author":"Xia","year":"2017","journal-title":"Mol. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"687938","DOI":"10.1155\/2015\/687938","article-title":"Glycolipid metabolism disorder in the liver of obese mice is improved by TUDCA via the restoration of defective hepatic autophagy","volume":"2015","author":"Guo","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12011-015-0474-5","article-title":"Effect of tauroursodeoxycholic acid and 4-phenylbutyric acid on metabolism of copper and zinc in type 1 diabetic mice model","volume":"170","author":"Zhou","year":"2016","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12011-018-1494-8","article-title":"Effect of 4-phenylbutyric acid and tauroursodeoxycholic acid on magnesium and calcium metabolism in streptozocin-induced type 1 diabetic mice","volume":"189","author":"Zhou","year":"2019","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.metabol.2009.04.035","article-title":"Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus","volume":"58","author":"Viktorinova","year":"2009","journal-title":"Metabolism"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cmet.2015.06.010","article-title":"Calcium homeostasis and organelle function in the pathogenesis of obesity and diabetes","volume":"22","author":"Arruda","year":"2015","journal-title":"Cell Metab."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yjmcc.2010.10.023","article-title":"Endoplasmic reticulum chaperon tauroursodeoxycholic acid alleviates obesity-induced myocardial contractile dysfunction","volume":"50","author":"Sreejayan","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10495-016-1296-4","article-title":"The role of endoplasmic reticulum stress in neurodegenerative disease","volume":"22","author":"Xiang","year":"2017","journal-title":"Apoptosis"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","article-title":"Altered bile acid profile associates with cognitive impairment in Alzheimer\u2019s disease-An emerging role for gut microbiome","volume":"15","author":"MahmoudianDehkordi","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2012.09.003","article-title":"Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP\/PS1 mice","volume":"50","author":"Lo","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12035-012-8256-y","article-title":"TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-\u03b2 deposition in APP\/PS1 mice","volume":"45","author":"Nunes","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3727\/096020198389960","article-title":"Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson\u2019s disease","volume":"11","author":"Duan","year":"2002","journal-title":"Cell Transplant."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.bbadis.2017.06.004","article-title":"Novel insights into the antioxidant role of tauroursodeoxycholic acid in experimental models of Parkinson\u2019s disease","volume":"1863","author":"Rosa","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.expneurol.2017.05.009","article-title":"Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson\u2019s disease","volume":"295","author":"Moreira","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Graham, S.F., Rey, N.L., Ugur, Z., Yilmaz, A., Sherman, E., Maddens, M., Bahado-Singh, R.O., Becker, K., Schulz, E., and Meyerdirk, L.K. (2018). Metabolomic profiling of bile acids in an experimental model of prodromal Parkinson\u2019s disease. Metabolites, 8.","DOI":"10.3390\/metabo8040071"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.1007\/s12035-018-1062-4","article-title":"Tauroursodeoxycholic acid improves motor symptoms in a mouse model of Parkinson\u2019s disease","volume":"55","author":"Rosa","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/exnr.2001.7755","article-title":"A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington\u2019s disease","volume":"171","author":"Keene","year":"2001","journal-title":"Exp. Neurol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/ene.12664","article-title":"Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis","volume":"23","author":"Elia","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/WNF.0b013e3181c47569","article-title":"Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic acid in patients with amyotrophic lateral sclerosis","volume":"33","author":"Parry","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3346\/jkms.2012.27.2.200","article-title":"Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: A randomized cross-over trial","volume":"27","author":"Min","year":"2012","journal-title":"J. Korean Med. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"7660","DOI":"10.1128\/JVI.01165-15","article-title":"Bile acids reduce prion conversion, reduce neuronal loss, and prolong male survival in models of Prion disease","volume":"89","author":"Cortez","year":"2015","journal-title":"J. Virol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"28077","DOI":"10.3390\/ijms161226083","article-title":"Critical role of endoplasmic reticulum stress in cognitive impairment induced by microcystin-LR","volume":"16","author":"Cai","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00401-016-1655-9","article-title":"Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy","volume":"133","author":"Launay","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molmed.2007.12.001","article-title":"Bile acids and apoptosis modulation: An emerging role in experimental Alzheimer\u2019s disease","volume":"14","author":"Ramalho","year":"2008","journal-title":"Trends Mol. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.1073\/pnas.162362299","article-title":"Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington\u2019s disease","volume":"99","author":"Keene","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/BF03401828","article-title":"Bilirubin and amyloid-beta peptide induce cytochrome c release through mitochondrial membrane permeabilization","volume":"6","author":"Rodrigues","year":"2000","journal-title":"Mol. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1471-4159.2006.04007.x","article-title":"Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer\u2019s disease mutant neuroblastoma cells","volume":"98","author":"Ramalho","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/DDDT.S130514","article-title":"Proteinopathy, oxidative stress and mitochondrial dysfunction: Cross talk in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"11","author":"Ganguly","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1471-4159.2010.07092.x","article-title":"Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degeneration","volume":"116","author":"Oveson","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tox.2011.11.020","article-title":"Ursodeoxycholic acid suppresses mitochondria-dependent programmed cell death induced by sodium nitroprusside in SH-SY5Y cells","volume":"292","author":"Chun","year":"2012","journal-title":"Toxicology"},{"key":"ref_145","first-page":"716871","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"2011","author":"Keane","year":"2011","journal-title":"Parkinson\u2019s Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13062-017-0176-3","article-title":"Post translational modification of parkin","volume":"12","author":"Chakraborty","year":"2017","journal-title":"Biol. Direct."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/srep01002","article-title":"PINK1-mediated phosphorylation of the parkin ubiquitin-like domain primes mitochondrial translocation of parkin and regulates mitophagy","volume":"2","author":"Imai","year":"2012","journal-title":"Sci. Rep."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1021\/acs.jproteome.8b00224","article-title":"Biochemical profiling of the brain and blood metabolome in a mouse model of prodromal Parkinson\u2019s disease reveals distinct metabolic profiles","volume":"17","author":"Graham","year":"2018","journal-title":"J. Proteom. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12974-014-0186-3","article-title":"Microglia activation in a model of retinal degeneration and TUDCA neuroprotective effects","volume":"11","author":"Noailles","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Mantopoulos, D., Murakami, Y., Comander, J., Thanos, A., Roh, M., Miller, J.W., and Vavvas, D.G. (2011). Tauroursodeoxycholic acid (TUDCA) protects photoreceptors from cell death after experimental retinal detachment. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024245"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12177-009-9030-x","article-title":"Bile acids in treatment of ocular disease","volume":"2","author":"Boatright","year":"2009","journal-title":"J. Ocul. Biol. Dis. Infor."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1167\/iovs.11-7496","article-title":"Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats","volume":"52","author":"Lax","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_153","first-page":"1706","article-title":"Tool from ancient pharmacopoeia prevents vision loss","volume":"12","author":"Boatright","year":"2006","journal-title":"Mol. Vis."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1167\/iovs.07-1012","article-title":"Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30","volume":"49","author":"Phillips","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1167\/iovs.11-8544","article-title":"TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice","volume":"53","author":"Drack","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1167\/iovs.12-9851","article-title":"Chemical chaperone TUDCA preserves cone photoreceptors in a mouse model of Leber congenital amaurosis","volume":"53","author":"Zhang","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1167\/iovs.15-17301","article-title":"Effects of tauroursodeoxycholic acid and alpha-lipoic-acid on the visual response properties of cat retinal ganglion cells: An in vitro study","volume":"56","author":"Xia","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Vicente, V., Lax, P., Fernandez-Sanchez, L., Rondon, N., Esquiva, G., Germain, F., de la Villa, P., and Cuenca, P. (2015). Neuroprotective effect of tauroursodeoxycholic acid on N-methyl-D-aspartate-induced retinal ganglion cell degeneration. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0137826"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1167\/iovs.14-15962","article-title":"TUDCA promotes phagocytosis by retinal pigment epithelium via MerTK activation","volume":"56","author":"Murase","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.biopha.2018.06.046","article-title":"Tauroursodeoxycholic acid alleviates hepatic ischemia reperfusion injury by suppressing the function of Kupffer cells in mice","volume":"106","author":"Xu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"e98101","DOI":"10.1172\/jci.insight.98101","article-title":"Conjugated bile acids attenuate allergen-induced airway inflammation and hyperresponsiveness by inhibiting UPR transducers","volume":"4","author":"Nakada","year":"2019","journal-title":"JCI Insight."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1742-2094-11-50","article-title":"Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation","volume":"11","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1007\/s12035-016-0142-6","article-title":"TGF\u03b2 Contributes to the anti-inflammatory effects of tauroursodeoxycholic acid on an animal model of acute neuroinflammation","volume":"54","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Castro, I., Albornoz, N., Aguilera, S., Barrera, M.J., Gonz\u00e1lez, S., N\u00fa\u00f1ez, M., Carvajal, P., Jara, D., Lagos, C., and Molina, C. (2019). Aberrant MUC1 accumulation in salivary glands of Sj\u00f6gren\u2019s syndrome patients is reversed by TUDCA in vitro. Rheumatology.","DOI":"10.1093\/rheumatology\/kez316"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Yun, S.P., Yoon, Y.M., Lee, J.H., Kook, M., Han, Y.S., Jung, S.K., and Lee, S.H. (2018). Tauroursodeoxycholic acid protects against the effects of P-Cresol-induced reactive oxygen species via the expression of cellular Prion protein. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020352"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s10620-014-3217-0","article-title":"Tauroursodeoxycholic acid attenuates progression of steatohepatitis in mice fed a methionine\u2013choline-deficient diet","volume":"59","author":"Cho","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bph.14095","article-title":"Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease","volume":"175","author":"Wang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1177\/0960327117734621","article-title":"Effect of tauroursodeoxycholic acid on PUFA levels and inflammation in an animal and cell model of hepatic endoplasmic reticulum stress","volume":"37","author":"Aslan","year":"2018","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"L1243","DOI":"10.1152\/ajplung.00396.2015","article-title":"Effect of a chemical chaperone, tauroursodeoxycholic acid, on HDM-induced allergic airway disease","volume":"310","author":"Siddesha","year":"2016","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1038\/s41598-018-21621-5","article-title":"Anti-inflammatory effect of Tauroursodeoxycholic acid in RAW 264.7 macrophages, Bone marrow-derived macrophages, BV2 microglial cells, and spinal cord injury","volume":"8","author":"Seong","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"e13227","DOI":"10.1111\/apha.13227","article-title":"Tauroursodeoxycholic acid (TUDCA) abolishes chronic high salt-induced renal injury and inflammation","volume":"226","author":"Miguel","year":"2019","journal-title":"Acta Physiol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"5729710","DOI":"10.1155\/2019\/5729710","article-title":"The role of the ER-induced UPR pathway and the efficacy of its inhibitors and inducers in the inhibition of tumor progression","volume":"2019","author":"Walczak","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2016.206","article-title":"Proteasome inhibitors in cancer therapy","volume":"14","author":"Manasanch","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2147\/IJN.S158393","article-title":"Silica nanoparticle-induced oxidative stress and mitochondrial damage is followed by activation of intrinsic apoptosis pathway in glioblastoma cells","volume":"13","author":"Kusaczuk","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"G973","DOI":"10.1152\/ajpgi.00270.2003","article-title":"Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways","volume":"286","author":"Alpini","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"28011","DOI":"10.18632\/oncotarget.4377","article-title":"Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure","volume":"6","author":"Vandewynckel","year":"2015","journal-title":"Oncotarget"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.3892\/ol.2016.4842","article-title":"Tauroursodeoxycholic acid reduces the invasion of MDA-MB-231 cells by modulating matrix metalloproteinases 7 and 13","volume":"12","author":"Park","year":"2013","journal-title":"Oncol. Lett."},{"key":"ref_178","first-page":"2585","article-title":"Ursodeoxycholic acid attenuates 5-fluorouracil-induced mucositis in a rat model","volume":"16","author":"Kim","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_179","first-page":"213","article-title":"Apoptosis induced by ursodeoxycholic acid in human melanoma cells through the mitochondrial pathway","volume":"41","author":"Yu","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_180","first-page":"925","article-title":"Explanation of colon cancer pathophysiology through analyzing the disrupted homeostasis of bile acids","volume":"14","author":"Dongfeng","year":"2014","journal-title":"Afr. Health Sci."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/jgh.14526","article-title":"Tauroursodeoxycholic acid attenuates colitis-associated colon cancer by inhibiting nuclear factor kappaB signaling","volume":"34","author":"Kim","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ene.12691","article-title":"The TUDCA trial--innovative trial designs for amyotrophic lateral sclerosis drugs?","volume":"23","author":"Ludolph","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"101144","DOI":"10.1016\/j.redox.2019.101144","article-title":"TUDCA-treated chronic kidney disease-derived hMSCs improve therapeutic efficacy in ischemic disease via PrPC","volume":"22","author":"Yoon","year":"2019","journal-title":"Redox Biol."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Qu, P., Ma, X., Qiao, F., Ma, Y., Qing, S., Zhang, Y., Wang, Y., and Cui, W. (2018). Tauroursodeoxycholic acid (TUDCA) alleviates endoplasmic reticulum stress of nuclear donor cells under serum starvation. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196785"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Sun, S., Zhao, B., Qi, M., Yao, Y., Xu, L., Ji, R., Chen, W., Wang, J., Huang, S., and Ma, L. (2019). Tudca Ameliorates Liver Injury Via Activation of SIRT1-FXR Signaling in a Rat Hemorrhagic Shock Model. Shock.","DOI":"10.1097\/SHK.0000000000001351"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"105665","DOI":"10.1016\/j.intimp.2019.05.050","article-title":"TUDCA attenuates intestinal injury and inhibits endoplasmic reticulum stress-mediated intestinal cell apoptosis in necrotizing enterocolitis","volume":"74","author":"Li","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1039\/C9BM00426B","article-title":"Tauroursodeoxycholic acid (TUDCA) counters osteoarthritis by regulating intracellular cholesterol levels and membrane fluidity of degenerated chondrocytes","volume":"7","author":"Arai","year":"2019","journal-title":"Biomater. Sci."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3892\/ijmm.2015.2295","article-title":"Tauroursodeoxycholic acid suppresses endoplasmic reticulum stress in the chondrocytes of patients with osteoarthritis","volume":"36","author":"Liu","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"e12195","DOI":"10.14814\/phy2.12195","article-title":"Reversal of glucose intolerance in rat offspring exposed to ethanol before birth through reduction of nuclear skeletal muscle HDAC expression by the bile acid TUDCA","volume":"2","author":"Yao","year":"2014","journal-title":"Physiol. Rep."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Yao, X.H., Nguyen, H.K., and Nyomba, B.L. (2013). Prenatal ethanol exposure causes glucose intolerance with increased hepatic gluconeogenesis and histone deacetylases in adult rat offspring: Reversal by tauroursodeoxycholic acid. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059680"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/21553769.2016.1249033","article-title":"Epigenetics: From the past to the present","volume":"9","year":"2016","journal-title":"Front. Life Sci."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"60","DOI":"10.18544\/PEDM-22.02.0052","article-title":"Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients","volume":"22","author":"Wawryka","year":"2016","journal-title":"Pediatr. Endocrinol. Diabetes Metab."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.3390\/ijms13078882","article-title":"Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: Ursodeoxycholic acid freezes regeneration & induces hibernation mode","volume":"13","author":"Kotb","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1007\/s10620-011-1763-2","article-title":"In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment","volume":"56","author":"Rudolph","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1194\/jlr.R900007-JLR200","article-title":"Bile acids as regulatory molecules","volume":"50","author":"Hylemon","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/cmdc.201300059","article-title":"Synthesis and evaluation of water-soluble prodrugs of ursodeoxycholic acid (UDCA), an anti-apoptotic bile acid","volume":"8","author":"Dosa","year":"2013","journal-title":"Chem. Med. Chem."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12934-019-1076-2","article-title":"Large-scale production of tauroursodeoxycholic acid products through fermentation optimization of engineered Escherichia coli cell factory","volume":"18","author":"Xu","year":"2019","journal-title":"Microbial Cell Factories"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajps.2017.11.001","article-title":"Preparation and toxicity evaluation of a novel nattokinase- tauroursodeoxycholate complex","volume":"13","author":"Feng","year":"2018","journal-title":"Asian J. Pharm. Sci."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/12\/1471\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:36:01Z","timestamp":1760189761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/12\/1471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":198,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["cells8121471"],"URL":"https:\/\/doi.org\/10.3390\/cells8121471","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,20]]}}}